SIM
VTVT icon

Spark Investment Management’s vTv Therapeutics VTVT Stock Holding History

Spark Investment Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-605
Closed -$46K – 268
2020
Q1 		$46K Buy
+605
New +$58.2K 0.02% 317

Other funds holding VTVT

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Spark Investment Management's VTVT Position: Q2 2020 in Review

Spark Investment Management sold out of vTv Therapeutics (VTVT) in Q2 2020, closing a stake of 605 shares — an estimated $46K sold.

Spark Investment Management first reported a position in VTVT in Q1 2020 and held it in 1 quarter. The position peaked at $46K in Q1 2020. 39 funds tracked by Wall St. Rank hold VTVT as of Q2 2020.

  • Spark Investment Management reported no remaining vTv Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 605 vTv Therapeutics shares in Q2 2020, an estimated $46K.
  • Spark Investment Management first reported a position in vTv Therapeutics in Q1 2020 and held it in 1 quarter.
  • Spark Investment Management's vTv Therapeutics position peaked at $46K in Q1 2020.
  • 39 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.